Ocrelizumab for multiple sclerosis

Overview of attention for article published in Cochrane database of systematic reviews, May 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

news: 1 news outlet
blogs: 1 blog
twitter: 12 X users

facebook: 3 Facebook pages
wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 76 Mendeley

Summary News Blogs X Facebook Wikipedia Dimensions citations

So far, Altmetric has seen 1 news story.

Stem cell therapy could protect cognition in progressive MS

Medical News Today, 03 Dec 2023

Share on PinterestStem cell therapy could help halt the progression of cognitive impairment in multiple sclerosis.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.